Innovative Technologies

to break through the barriers to hepatitis C treatment

An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.

The HepCure Provider Dashboard

HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.

Register to Join

 

Through the use of the dashboard and patient app, providers can:

  • Track data over time and organize patients by common characteristics.
  • Coordinate efficient care that improves health outcomes.
  • Identify patients who are due for preventive visits and screenings and monitor symptoms, side effects as well as exchange labs through the patient app.
  • Monitor a patient’s progress through each phase of treatment with built in access to social and behavioral health assessments.
  • Improve overall quality of care and enable access anytime, anywhere.
  • Access clinical decision-support algorithms, updates as new medications and regimens become available.

Upcoming Features

We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:

  • Integrate HepCure into electronic medical record systems
  • Allow for providers to assign cases to a local specialist
  • Have suggestions or feedback? Share it with us!

HepCure Patient App

The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.

Learn More

HepCure Live Webinars

The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.

All webinars are held on Tuesdays from 4:30 - 5:30pm EST

Next Webinar

Hepatitis Debrief: The Liver Meeting 2019

On Tuesday, February 18th Dr. Marc Ghany of Liver Disease Brach, NIDDK, NIH presented on:

“Hepatitis Debrief: The Liver Meeting 2019”

Lecture Objectives:

  1. Participants will gain knowledge on novel regimens under development for chronic hepatitis B.
  2. Participants will gain knowledge on the benefits of sustained virological response for patients with chronic hepatitis C.
  3. Participants will better understand the outcomes and management of donation of organs from HCV positive donors to HCV negative recipients.

Presenter Bio:

Dr. Ghany received his medical education at the Royal College of Surgeons in Dublin, Ireland. He obtained a Masters in Clinical Research from Duke University. Dr. Ghany was a staff-physician from 2000-2015 at the Warren Magnuson Clinical Center. In 2015, he transitioned to Clinical Tenure Track within the Liver Diseases Branch, NIDDK, NIH.

Dr. Ghany has been conducting research on the natural history and therapy of chronic viral hepatitis for the past twenty-five years. He has published 167 peer reviewed manuscripts, reviews and editorials on the natural history and treatment of chronic hepatitis B and C. Dr Ghany is co-chair of the American Association for the Study of Liver Diseases hepatitis C practice guidelines committee and co-author of the American Association for the Study of liver diseases hepatitis C practice guidelines. He has achieved national and international recognition for his work on the natural history and management of chronic viral hepatitis B and C. He has served as an advisor for the CDC, NASEM and FDA. He is a Principal Investigator on 7 natural history and clinical trials in the Liver Diseases Branch, NIDDK and currently serves as a Principal Investigator on the NIH-funded Hepatitis B Research Network and is an associate editor of the journal Hepatology.

Access the slides here

Last Webinar

Monitoring of Hepatitis B

On Tuesday, February 11th Dr. Ponni Perumalswami of the Icahn School of Medicine at Mount Sinai presented on:

“Monitoring of Hepatitis B”

Learning Objectives:

  1. Determine appropriate patient monitoring while on HBV therapy.
  2. Demonstrate which patients with HBV should be  screened for hepatocellular carcinoma (HCC).
  3. Appreciate the differences in monitoring cirrhotic and non-cirrhotic patients with HBV.

Presenters Bio:

Dr. Perumalswami is an Associate Professor of Medicine in the Department of Medicine, Division of Liver Diseases and Recanati Miller Transplant Institute at Mount Sinai Hospital. As a hepatologist, her research interests are in health services and clinical outcomes with a focus on viral hepatitis and liver cancer.

Access the slides here

Watch This Webinar

Watch Archived Webinars

Beginner Modules

These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.

Launch

Expert Modules

These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.

Launch

Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment

THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.

This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.

Launch